MedTrace Logo

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy.

NCT00603746 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 627

Last updated 2017-09-15

Study results available
· View outcomes & findings →

Summary

This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.

Conditions

Interventions

DRUG

GW685698X

GW685698X

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-01
Primary Completion
2008-09-01
Completion
2008-09-20

Countries

  • United States
  • Australia
  • Bulgaria
  • Canada
  • Chile
  • Czechia
  • Estonia
  • France
  • Germany
  • Mexico
  • Netherlands
  • Peru
  • Poland
  • Russia
  • South Africa
  • Thailand

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00603746 on ClinicalTrials.gov